Battelle Ventures, based in Princeton, New Jersey, focuses on investing in healthcare, B2B, TMT, and industrial sectors. With a combined $255 million under management, the firm works closely with technology transfer offices of National Laboratories and university tech transfer departments to create and accelerate the development of breakthrough technology startups. The fund has a preference for startups with 6-10 years of age and typically invests in rounds with 3-4 participants. Some of its successful portfolio startups include Rajant Corporation, Proterro, and Hepregen, with a focus on therapeutics and biotechnology.